-
A Legacy of Leadership and Hope: The Elaine and Eduardo Saverin Foundation’s generational commitment to patients with metastatic breast cancer
The Elaine and Eduardo Saverin Foundation has made an extraordinary $20 million grant to Dana-Farber Cancer Institute to accelerate research and care for people living with stage IV breast cancer.
-
Jimmy Fund Walk steps into record-breaking year with over $11.2 million raised
On a sunny Sunday in October 2025, the Jimmy Fund Walk presented by Hyundai, Dana-Farber Cancer Institute’s signature fundraising event, crossed more than just the finish line at Boston Common.
-
An un-fore-gettable year with Jimmy Fund Golf
Jimmy Fund Golf presented by Mohegan Sun raised $6.8 million in 2024, thanks to organizers and participants in more than 140 events across the country.
-
Levy gift supports Dana-Farber’s vision for the future of cancer care
When Sarah Salter Levy and Steven Levy learned of Dana-Farber Cancer Institute’s plans to build New England’s first inpatient hospital dedicated to adults with cancer, they wanted to be among the first to step forward with philanthropic support.
-
Your generosity on GivingTuesday is fueling the next victory over cancer
In 2012, GivingTuesday was created with one simple goal: encourage generosity and collective giving. What was once a small experiment in communal impact is now a worldwide movement comprised of donors who support causes close to their hearts.
-
Alex’s Lemonade Stand Foundation continues steadfast support
The legacy of a remarkable little girl has guided the mission of Alex’s Lemonade Stand Foundation (ALSF) since it was established in 2005.
-
Freedlander bequest focuses on inflammatory breast cancer
The estate of Ruth Freedlander made a $1.8 million bequest to Dana-Farber Cancer Institute that will advance research into inflammatory breast cancer (IBC), a rare and aggressive disease that is particularly difficult to treat.
-
CRI grants accelerate immunotherapy research at Dana-Farber
The Cancer Research Institute (CRI) is advancing bold new strategies to harness the immune system against cancer through two grants at Dana-Farber Cancer Institute.
-
IWMF awards $1.4 million to Dana-Farber investigators, fueling Waldenstrom’s Macroglobulinemia research
For more than two decades, the International Waldenstrom’s Macroglobulinemia Foundation (IWMF) has been a vital philanthropic partner to Dana-Farber Cancer Institute, accelerating research into Waldenstrom’s macroglobulinemia (WM), a rare, slow-growing blood cancer.
-
Dana-Farber’s Boston half team sets new record
Sunday, November 9, marked the Boston Athletic Association’s (B.A.A.’s) annual Boston Half, a scenic 13.1-mile race through Franklin Park and the Emerald Necklace Park System.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.